Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
4
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
cancer
cvs health
department of health and human services
drug prices
investing
medicaid
novartis
pfizer
president trump
roche
abeona therapeutics
What
drug
4
×
plan
4
×
prices
awaited
bio
details
house
long
lower
prescription
roundup
advantages
afternoon
alzheimer’s
anathema
anticipated
bar
blueprint
brings
companies
cost
cut
democrat
different
drugs
elements
expect
fail
gamble
gene
increases
latest
leaked
look
market
meant
medco’s
monday
mover
new
Language
unset
Current search:
drug
×
" raleigh-durham blog main "
×
" national blog main "
×
plan
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details